The ratio of IGF-1 to IGFBP3, the latter being the predominant carrier of IGF-1 in the bloodstream, has been proposed as an indicator of IGF-1's biological availability and may serve as a prognostic marker for the effectiveness of chemotherapy in NSCLC.116. Here, IGF1 is linked to non-small cell lung carcinoma.